OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Addressing insurance‐related barriers to novel antiobesity medications: Lessons to be learned from bariatric surgery
Hamlet Gasoyan, David B. Sarwer
Obesity (2022) Vol. 30, Iss. 12, pp. 2338-2339
Closed Access | Times Cited: 10
Hamlet Gasoyan, David B. Sarwer
Obesity (2022) Vol. 30, Iss. 12, pp. 2338-2339
Closed Access | Times Cited: 10
Showing 10 citing articles:
One-Year Weight Reduction With Semaglutide or Liraglutide in Clinical Practice
Hamlet Gasoyan, Elizabeth R. Pfoh, Rebecca Schulte, et al.
JAMA Network Open (2024) Vol. 7, Iss. 9, pp. e2433326-e2433326
Open Access | Times Cited: 16
Hamlet Gasoyan, Elizabeth R. Pfoh, Rebecca Schulte, et al.
JAMA Network Open (2024) Vol. 7, Iss. 9, pp. e2433326-e2433326
Open Access | Times Cited: 16
Early‐ and later‐stage persistence with antiobesity medications: A retrospective cohort study
Hamlet Gasoyan, Elizabeth R. Pfoh, Rebecca Schulte, et al.
Obesity (2023) Vol. 32, Iss. 3, pp. 486-493
Open Access | Times Cited: 35
Hamlet Gasoyan, Elizabeth R. Pfoh, Rebecca Schulte, et al.
Obesity (2023) Vol. 32, Iss. 3, pp. 486-493
Open Access | Times Cited: 35
Association of patient characteristics and insurance type with anti‐obesity medications prescribing and fills
Hamlet Gasoyan, Elizabeth R. Pfoh, Rebecca Schulte, et al.
Diabetes Obesity and Metabolism (2024) Vol. 26, Iss. 5, pp. 1687-1696
Open Access | Times Cited: 12
Hamlet Gasoyan, Elizabeth R. Pfoh, Rebecca Schulte, et al.
Diabetes Obesity and Metabolism (2024) Vol. 26, Iss. 5, pp. 1687-1696
Open Access | Times Cited: 12
Cost-Effectiveness of Pharmacotherapy for the Treatment of Obesity in Adolescents
Francesca Lim, Brandon K. Bellows, Sarah Xinhui Tan, et al.
JAMA Network Open (2023) Vol. 6, Iss. 8, pp. e2329178-e2329178
Open Access | Times Cited: 17
Francesca Lim, Brandon K. Bellows, Sarah Xinhui Tan, et al.
JAMA Network Open (2023) Vol. 6, Iss. 8, pp. e2329178-e2329178
Open Access | Times Cited: 17
Trends and Disparities in Newer GLP1 Receptor Agonist Initiation among Real-World Adult Patients Eligible for Obesity Treatment
Rotana M. Radwan, Yao An Lee, Pareeta Kotecha, et al.
medRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Rotana M. Radwan, Yao An Lee, Pareeta Kotecha, et al.
medRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Regional trends and disparities in newer GLP1 receptor agonist initiation among real‐world adult patients eligible for obesity treatment
Rotana M. Radwan, Yao An Lee, Pareeta Kotecha, et al.
Diabetes Obesity and Metabolism (2025)
Closed Access
Rotana M. Radwan, Yao An Lee, Pareeta Kotecha, et al.
Diabetes Obesity and Metabolism (2025)
Closed Access
Lifetime Health Effects and Cost-Effectiveness of Tirzepatide and Semaglutide in US Adults
Jennifer H. Hwang, Neda Laiteerapong, Elbert S. Huang, et al.
JAMA Health Forum (2025) Vol. 6, Iss. 3, pp. e245586-e245586
Open Access
Jennifer H. Hwang, Neda Laiteerapong, Elbert S. Huang, et al.
JAMA Health Forum (2025) Vol. 6, Iss. 3, pp. e245586-e245586
Open Access
Weight-centric prevention of cancer
Diego Añazco, Andrés Acosta, Elizabeth Cathcart-Rake, et al.
Obesity Pillars (2024) Vol. 10, pp. 100106-100106
Open Access | Times Cited: 1
Diego Añazco, Andrés Acosta, Elizabeth Cathcart-Rake, et al.
Obesity Pillars (2024) Vol. 10, pp. 100106-100106
Open Access | Times Cited: 1
Medically Supervised Weight Loss and Effects of Anti-Obesity Medications
Amy J. Sheer, William T. Donahoo, Crystal Johnson-Mann
(2024), pp. 155-175
Closed Access
Amy J. Sheer, William T. Donahoo, Crystal Johnson-Mann
(2024), pp. 155-175
Closed Access
IFSO/ASMBS Guidelines Expand Criteria for Bariatric Surgery: Will the Coverage by Third-Party Payors Follow?
Hamlet Gasoyan, David B. Sarwer
Obesity Surgery (2022) Vol. 33, Iss. 2, pp. 672-673
Closed Access
Hamlet Gasoyan, David B. Sarwer
Obesity Surgery (2022) Vol. 33, Iss. 2, pp. 672-673
Closed Access
